Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,978 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
Huang Y, Sharma VK, Robinson T, Lindley RI, Chen X, Kim JS, Lavados P, Olavarría V, Arima H, Fuentes S, Nguyen HT, Lee TH, Parsons MW, Levi C, Demchuk AM, Bath PM, Broderick JP, Donnan GA, Martins S, Pontes-Neto OM, Silva F, Pandian J, Ricci S, Stapf C, Woodward M, Wang J, Chalmers J, Anderson CS; ENCHANTED investigators. Huang Y, et al. Among authors: chalmers j. Int J Stroke. 2015 Jul;10(5):778-88. doi: 10.1111/ijs.12486. Epub 2015 Apr 2. Int J Stroke. 2015. PMID: 25832995 Clinical Trial.
Clinical implications of PROGRESS: questions and answers.
Chalmers J, Adams HP Jr, Donnan GA, Fox K, MacMahon S, Mancia G, Tzourio C. Chalmers J, et al. J Hypertens Suppl. 2003 Jun;21(5):S21-4. doi: 10.1097/00004872-200306005-00005. J Hypertens Suppl. 2003. PMID: 12953852 No abstract available.
Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk.
Ohkubo T, Chapman N, Neal B, Woodward M, Omae T, Chalmers J; Perindopril Protection Against Recurrent Stroke Sutdy Collaborative Group. Ohkubo T, et al. Among authors: chalmers j. Am J Respir Crit Care Med. 2004 May 1;169(9):1041-5. doi: 10.1164/rccm.200309-1219OC. Epub 2004 Feb 27. Am J Respir Crit Care Med. 2004. PMID: 14990394 Clinical Trial.
Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region.
Rodgers A, Chapman N, Woodward M, Liu LS, Colman S, Lee A, Chalmers J, MacMahon S; Perindopril Protection against Recurrent Stroke Study Collaborative Group. Rodgers A, et al. Among authors: chalmers j. J Hypertens. 2004 Mar;22(3):653-9. doi: 10.1097/00004872-200403000-00030. J Hypertens. 2004. PMID: 15076173 Clinical Trial.
Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan.
Hasegawa Y, Yamaguchi T, Omae T, Woodward M, Chalmers J; PROGRESS CT Substudy Investigators. Hasegawa Y, et al. Among authors: chalmers j. Hypertens Res. 2004 Mar;27(3):147-56. doi: 10.1291/hypres.27.147. Hypertens Res. 2004. PMID: 15080373 Free article. Clinical Trial.
Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.
Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J, Woodward M, MacMahon S; Blood Pressure Lowering Treatment Trialists' Collaboration. Turnbull F, et al. Among authors: chalmers j. Arch Intern Med. 2005 Jun 27;165(12):1410-9. doi: 10.1001/archinte.165.12.1410. Arch Intern Med. 2005. PMID: 15983291
1,978 results